z-logo
open-access-imgOpen Access
Cutting Edge: The RNA-Binding Protein Ewing Sarcoma Is a Novel Modulator of Lymphotoxin β Receptor Signaling
Author(s) -
Richard VirgenSlane,
Ricardo G. Correa,
Parham Ramezani-Rad,
Seth Steen-Fuentes,
Thiago Detanico,
Michael J. DiCandido,
Jun Li,
Carl F. Ware
Publication year - 2020
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1901260
Subject(s) - lymphotoxin , lymphotoxin beta receptor , microbiology and biotechnology , signal transduction , biology , immune system , mapk/erk pathway , proinflammatory cytokine , receptor , tumor necrosis factor alpha , cancer research , chemistry , immunology , inflammation , biochemistry
Lymphotoxin β receptor (LTβR) signaling is crucial for lymphoid tissue organogenesis and immune homeostasis. To identify novel regulatory mechanisms for signaling, we implemented a two-step screen that uses coexpression analysis of human fibroblasts undergoing LTβR stimulation and affinity-purification mass spectrometry for the LTβR signaling protein TNFR-associated factor 3 (TRAF3). We identify Ewing sarcoma (EWS) protein as a novel LTβR signaling component that associates with TRAF3 but not with TNFR-associated factor 2 (TRAF2). The EWS:TRAF3 complex forms under unligated conditions that are disrupted following activation of the LTβR. We conclude that EWS limits expression of proinflammatory molecules, GM-CSF, and ERK-2, promoting immune homeostasis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom